Managing older adults with diabetes

Journal of the American Academy of Nurse Practitioners

Volumn 18, Issue 7, 2006, Pages 309-317

  Hainer, Theresa A ^a  

^a EASTERN MAINE MEDICAL CENTER   (United States)

Author keywords

Diabetes; Insulin pumps; Intensive insulin therapy; Multiple daily injections; Older adults

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

AGED; DAILY LIFE ACTIVITY; DIABETIC DIET; EVIDENCE BASED MEDICINE; GERIATRIC ASSESSMENT; GERIATRIC NURSING; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INTENSIVE CARE; LIFESTYLE; MEDICARE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE PRACTITIONER; NURSING ASSESSMENT; ORGANIZATION AND MANAGEMENT; PATIENT CARE PLANNING; PATIENT SELECTION; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; REVIEW; UNITED STATES;

ACTIVITIES OF DAILY LIVING; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; ELIGIBILITY DETERMINATION; EVIDENCE-BASED MEDICINE; GERIATRIC ASSESSMENT; GERIATRIC NURSING; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; INTENSIVE CARE; LIFE STYLE; MEDICARE; NURSE PRACTITIONERS; NURSING ASSESSMENT; PATIENT CARE PLANNING; PATIENT SELECTION; PRACTICE GUIDELINES; PRIMARY HEALTH CARE; UNITED STATES;

EID: 33748658694     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2006.00136.x     Document Type: Article

References (40)

1. American Diabetes Association 2004). Standards of medical care for patients with diabetes mellitus. Diabetes Care, 25 (S 33 49.
2. American Diabetes Association 2005). Position statement: Standards of medical care in diabetes. Diabetes Care, 28 (S4-S36 1 67.
3. Bode, B., Steed, R. D. Davidson, P. C 1996). Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care, 19, 324 327.
4. Bohannon, N. J. V 2003). Optimizing insulin regimens in type 1 diabetes [Electronic version]. Postgraduate Medicine online, 113 (6 39 54.
5. Boland, E. A., Grey, M. Oesterle, A 1994). Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care, 22 (11 1779 1784.
6. Boyle, J. P., Honeycutt, A. A., Narayan, K. M., Geiss, L. S., Chen, H. Thompson, T. J 2001). Projection of diabetes burden through 2050: Impact of changing demography and disease prevalence in the U.S. Diabetes Care, 24 (11 1936 1940.
7. Brink, S. J. Stewart, C 1986). Insulin pump treatment in insulin-dependent diabetes mellitus. Children, adolescents, and young adults. JAMA, 255 (5 617 621.
8. Centers for Disease Control and Prevention 2002). National diabetes fact sheet: General information and national estimates on diabetes in the United States, 2000. Atlanta, GA : Author.
9. Centers for Medicare & Medicaid Services 2005). CMS manual system Medicare national coverage determinations subject: Insulin pumps: C-peptide levels as a criterion for use implementation date: February 18, 2005 (Pub. 100-03). Baltimore, MD : Department of Health and Human Services.
10. CMS Coverage and Analysis Group 1999, August 26). National coverage decision for insulin infusion pump (CAG-00041N). Centers for Medicare & Medicaid.
11. Cooppan, R 2003). The changing model of insulin use in type 2 diabetes [Electronic version]. Postgraduate Medicine online, 113 (6 59 64.
12. Cranston, I., Lomas, J., Maran, A., Macdonald, I Amiel, S. A 1994). Restoration of hypoglycaemia awareness in patients with long duration insulin-dependent diabetes. Lancet, 344, 283 287.
13. Dagogo-Jack, S., Rattarasarn, C. Cryer, P. E 1994). Reversal of hypoglycaemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes, 43 (1426 1434.
14. Defronzo, R. A., Ratner, R. E., Han, J., Kim, D. D., Fineman, M. S. Baron, A. D 2005). Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care, 28, 1092 1100.
15. Diabetes Control and Complications Trial Research Group 1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329, 977 986.
16. Farkas-Hirsch, R. F. Hirsch, I. B 1994). Continuous subcutaneous insulin infusion: A review of the past and its implementation for the future. Diabetes Spectrum, 7 (27), 80 84, 136 138.
17. Gabbe, S. G., Holing, E., Temple, P. Brown, Z. A 2000). Benefits, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. American Journal of Obstetrics and Gynecology, 182 (6 1283 1291.
18. Garg, S. K., Walker, A. J., Hoff, H. K., D'Souza, A. O., Gottlieb, P. A. Chase, H. P 2004). Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump. Diabetes Technology & Therapeutics, 6 (1 17 19.
19. Herbst, K. L 2002). Insulin strategies for primary care providers. Clinical Diabetes, 20, 11 17.
20. Hirsch, I. B 1998). Intensive treatment of type 1 diabetes. Medical Clinics of North America, 82, 689 719.
21. Hirsch, I. B., Farkas-Hirsch, R. Cryer, P. E 1991). Continuous subcutaneous insulin infusion for the treatment of diabetic patients with hypoglycemia unawareness. Diabetes, Nutrition & Metabolism, 4, 41 43.
22. Kendall, D. M., Riddle, M. C., Rosenstock, J., Zhuang, D., Kim, D. D., Fineman, M. S., et al 2005). Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care, 28, 1083 1091.
23. Lenhard, M. J. Maser, R. E 2001). Continuous subcutaneous insulin infusion (CSII) in patients with type 2 diabetes. Diabetes 50, 2 (Suppl 1837.
24. Masharani, U 2005). Diabetes mellitus and hypoglycemia. In L. M. Tierney, S. J. Mcphee M. A. Papadakis (Eds 2005 Current medical diagnosis and treatment (44th ed., pp. 1157 1201). New York : McGraw-Hill.
25. Medicare Insulin Pump Coverage Act 1999). Retrieved March 25, 2005, from http://thomas.loc.gov./cgi_bin/query/z?c106:S.617.IS
26. Medtronic Minimed 2005). Revised Medicare insulin pump coverage criteria: Patient eligibility decision tree. Retrieved September 25, 2005, from CMS Web site : www.cms.hhs.gov/manuals/pm_trans/R27ncd.pdf
27. Members of the California Healthcare Foundation, American Geriatrics Society, & Panel on Improving Care for Older Persons with DM 2003). AGS clinical practice guideline: Guidelines for improving care of the older person with diabetes mellitus. Journal of the American Geriatrics Society, 51, S265 S280.
28. Oki, J. C. Isley, W. L 2002). Diabetes mellitus. In J. T. DiPiro, R. L. Talbert, G. C. Yee, G. R. Matzke, B. G. Wells L. M. Posey (Eds Pharmacotherapy: A pathophysiologic approach (5th ed., pp. 1335 1358). New York : McGraw-Hill.
29. Pickup, J. Keen, H 2002). Continuous subcutaneous insulin infusion at 25 years: Evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care, 25, 593 598.
30. Raskin, P 2003). Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: A randomized, parallel-group, 24-week study. Diabetes Care, 26, 2598 2603.
31. Reynolds, L. R 2000). Reemergence of insulin pump therapy in the 1990's. Southern Medical Journal, 93 (12 1157 1160.
32. Rizvi, A. A 2002). Benefits of insulin pump therapy in the elderly. Geriatric Times, III (3), 1 9.
33. Rizvi, A. A., Arnold, M. B. Chakraborty, M 2001). Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes. Endocrine Practice, 5 (7 364 369.
34. Robert Wood Johnson Medical School & Liberty Communications Network 2004, July 1). Medical crossfire. Retrieved September 21, 2005, from http://www.multiculturalmedicine.com/online_learning/cme/04ada_diabetes.pdf
35. Saaddine, J. B., Engelgau, M. M., Beckles, G. L., Gregg, E. W., Thompson, T. J. Narayan, K. M 2002). A diabetes report card for the United States: Quality of care in the 1990's. Annals of Internal Medicine, 136, 565 574.
36. Tabak, A. G., Tamas, G., Zgibor, J., Wilson, R., Becker, D., Kerenyi, Z., et al 2000). Targets and reality: A comparison of health indicators in the U.S. (Pittsburgh Epidemiology of Diabetes Complications Study) and Hungary (DiabCare Hungary). Diabetes Care, 23, 1284 1289.
37. Testa, M. A., Haynes, J. F., Turner, R. R. Simonson, D. C 2001). Patient acceptance and satisfaction with intensive insulin therapy in type 2 diabetes: A randomized trial of the insulin pen vs. pump. Diabetes 50, 2 (Suppl 1781.
38. U.K. Prospective Diabetes Study Group 1998). Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risks of complications in patients with type 2 diabetes. Lancet, 352, 837 853.
39. Velussi, M 2002). Lispro insulin treatment in comparison with regular human insulin in type 2 diabetic patients living in nursing homes. Diabetes, Nutrition & Metabolism, 15 (2 96 100.
40. Wallace, L. A., Lee, S. L. Cooper, D. A 2005). Glycemic control in the ICU. Advance for Nurses, online edition. Retrieved April 29, 2006, from http://nursing.advanceweb.com/common/editorial/printfriendly.aspx?cc=48956